Up to the Moment

Surterra partners with Intrexon in $100 million licensing cannabinoid deal

Surterra Wellness, an Atlanta-based cannabis company with operations in Florida and Texas, announced it will partner with Hungary’s Intrexon Corp. in a $100 million licensing deal aimed at biosynthetic cannabinoid production. Surterra would use Intrexon’s proprietary yeast fermentation platform to boost its cannabinoid production. Surterra is a privately held company; […]

Supreme Cannabis Well-Positioned for Health Canada’s Final Regulations for New Cannabis Products

TORONTO, June 18, 2019 /PRNewswire/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) welcome’s Health Canada’s final regulations for new cannabis products (“Health Canada’s Regulations”) and reiterates its expanded product strategy. On June 14, 2019, Health Canada released to license holders […]

Surterra Enters $100 Million Cannabinoid Biosynthesis Deal with Intrexon

Intrexon Corporation and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production Exclusive Global Agreement to Transform Surterra’s Ability to Produce Specific Cannabinoids to Meet Growing Demand, Boost Innovation and Product Development BUDAPEST, Hungary and ATLANTA, June 18, 2019 /PRNewswire/ — Intrexon Corporation (Intrexon) (NASDAQ: XON), […]